Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of AEG35156 in Combination With Docetaxel in Patients With Solid Tumors

NCT00357747 is registered in ClinicalTrials.gov with NCIC Clinical Trials Group as lead sponsor.

NCT NCT00357747
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00357747 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of AEG35156 in Combination With Docetaxel in Patients With Solid Tumors
Lead sponsor
NCIC Clinical Trials Group
Phase
Phase 1
Overall status
Completed
Start date
June 9, 2005
Completion date
June 7, 2010
Enrollment
10 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

unspecified adult solid tumor, protocol specific